254 related articles for article (PubMed ID: 29616326)
1. Role of natural killer cells in lung cancer.
Aktaş ON; Öztürk AB; Erman B; Erus S; Tanju S; Dilege Ş
J Cancer Res Clin Oncol; 2018 Jun; 144(6):997-1003. PubMed ID: 29616326
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cell‑based immunotherapy for lung cancer: Challenges and perspectives (Review).
Zeng Y; Lv X; Du J
Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34498710
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells.
Carrega P; Morandi B; Costa R; Frumento G; Forte G; Altavilla G; Ratto GB; Mingari MC; Moretta L; Ferlazzo G
Cancer; 2008 Feb; 112(4):863-75. PubMed ID: 18203207
[TBL] [Abstract][Full Text] [Related]
4. MICA/IL-12: A novel bifunctional protein for killer cell activation.
Tietje A; Yang X; Yu X; Wei Y
Oncol Rep; 2017 Mar; 37(3):1889-1895. PubMed ID: 28098874
[TBL] [Abstract][Full Text] [Related]
5. Aerosol Delivery of Interleukin-2 in Combination with Adoptive Transfer of Natural Killer Cells for the Treatment of Lung Metastasis: Methodology and Effect.
Kiany S; Gordon N
Methods Mol Biol; 2016; 1441():285-95. PubMed ID: 27177675
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cell-mediated rejection of experimental human lung cancer by genetic overexpression of major histocompatibility complex class I chain-related gene A.
Busche A; Goldmann T; Naumann U; Steinle A; Brandau S
Hum Gene Ther; 2006 Feb; 17(2):135-46. PubMed ID: 16454647
[TBL] [Abstract][Full Text] [Related]
7. Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression.
Cong J; Wang X; Zheng X; Wang D; Fu B; Sun R; Tian Z; Wei H
Cell Metab; 2018 Aug; 28(2):243-255.e5. PubMed ID: 30033198
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of natural killer cell activity as a biomarker for predicting immunotherapy response in non-small cell lung cancer.
Choi MG; Kim YJ; Lee JC; Rho JK; Choi CM
Thorac Cancer; 2020 Nov; 11(11):3337-3345. PubMed ID: 33017518
[TBL] [Abstract][Full Text] [Related]
9. Rocaglamide enhances NK cell-mediated killing of non-small cell lung cancer cells by inhibiting autophagy.
Yao C; Ni Z; Gong C; Zhu X; Wang L; Xu Z; Zhou C; Li S; Zhou W; Zou C; Zhu S
Autophagy; 2018; 14(10):1831-1844. PubMed ID: 29969944
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cells for osteosarcoma.
Tarek N; Lee DA
Adv Exp Med Biol; 2014; 804():341-53. PubMed ID: 24924184
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced non-small cell lung cancer.
Lin M; Liang SZ; Wang XH; Liang YQ; Zhang MJ; Niu LZ; Chen JB; Li HB; Xu KC
Immunol Res; 2017 Aug; 65(4):880-887. PubMed ID: 28508945
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulant drugs increase natural killer cell activity in lung cancer.
Bobek V; Boubelik M; Fiserová A; L'uptovcová M; Vannucci L; Kacprzak G; Kolodzej J; Majewski AM; Hoffman RM
Lung Cancer; 2005 Feb; 47(2):215-23. PubMed ID: 15639720
[TBL] [Abstract][Full Text] [Related]
13. Adoptive transfer of natural killer cells promotes the anti-tumor efficacy of T cells.
Goding SR; Yu S; Bailey LM; Lotze MT; Basse PH
Clin Immunol; 2017 Apr; 177():76-86. PubMed ID: 27377534
[TBL] [Abstract][Full Text] [Related]
14. MULT1E/mIL-12: a novel bifunctional protein for natural killer cell activation.
Tietje A; Li J; Yu X; Wei Y
Gene Ther; 2014 May; 21(5):468-75. PubMed ID: 24572784
[TBL] [Abstract][Full Text] [Related]
15. Effect of smoking on human natural killer cell activity.
Phillips B; Marshall ME; Brown S; Thompson JS
Cancer; 1985 Dec; 56(12):2789-92. PubMed ID: 4052953
[TBL] [Abstract][Full Text] [Related]
16. Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.
Rabinowich H; Vitolo D; Altarac S; Herberman RB; Whiteside TL
J Immunol; 1992 Jul; 149(1):340-9. PubMed ID: 1535088
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cells and their therapeutic role in pancreatic cancer: A systematic review.
Van Audenaerde JRM; Roeyen G; Darcy PK; Kershaw MH; Peeters M; Smits ELJ
Pharmacol Ther; 2018 Sep; 189():31-44. PubMed ID: 29660367
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of interleukin-2 on natural killer activity in lung cancer patients.
Ito M; Suzuki H; Yamashita N; Sugiyama E; Maruyama M; Sato M; Iwata M; Yano S
Anticancer Res; 1984; 4(6):375-8. PubMed ID: 6097158
[TBL] [Abstract][Full Text] [Related]
19. Blocking transforming growth factor-β signaling pathway augments antitumor effect of adoptive NK-92 cell therapy.
Yang B; Liu H; Shi W; Wang Z; Sun S; Zhang G; Hu Y; Liu T; Jiao S
Int Immunopharmacol; 2013 Oct; 17(2):198-204. PubMed ID: 23806302
[TBL] [Abstract][Full Text] [Related]
20. A trial of autologous ex vivo-expanded NK cell-enriched lymphocytes with docetaxel in patients with advanced non-small cell lung cancer as second- or third-line treatment: phase IIa study.
Yang YJ; Park JC; Kim HK; Kang JH; Park SY
Anticancer Res; 2013 May; 33(5):2115-22. PubMed ID: 23645763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
